Roivant Sciences Files 8-K
Ticker: ROIV · Form: 8-K · Filed: Mar 19, 2025 · CIK: 1635088
Sentiment: neutral
Topics: 8-K, disclosure, regulatory
TL;DR
Roivant Sciences filed an 8-K on 3/19/25 covering disclosures and events.
AI Summary
Roivant Sciences Ltd. filed an 8-K on March 19, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits. The company's principal executive offices are located in London, United Kingdom.
Why It Matters
This 8-K filing provides updates and disclosures from Roivant Sciences Ltd. to the SEC, which are important for investors to understand the company's current status and any material events.
Risk Assessment
Risk Level: low — This filing is a routine 8-K report and does not appear to contain any immediately alarming or high-risk information.
Key Numbers
- 001-40782 — SEC File Number (Identifies the company's filing with the SEC)
- 98-1173944 — IRS Employer Identification No. (Company's tax identification number)
Key Players & Entities
- Roivant Sciences Ltd. (company) — Registrant
- March 19, 2025 (date) — Date of earliest event reported
- London (location) — Address of Principal Executive Offices
FAQ
What is the primary purpose of this 8-K filing by Roivant Sciences Ltd.?
The 8-K filing serves to report on various events, including Regulation FD Disclosures, Other Events, and Financial Statements and Exhibits, as of March 19, 2025.
Where are Roivant Sciences Ltd.'s principal executive offices located?
Roivant Sciences Ltd.'s principal executive offices are located at 7th Floor 50 Broadway, London SW1H 0DB, United Kingdom.
What is the SEC file number for Roivant Sciences Ltd.?
The SEC file number for Roivant Sciences Ltd. is 001-40782.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on March 19, 2025.
What is the Standard Industrial Classification code for Roivant Sciences Ltd.?
The Standard Industrial Classification code for Roivant Sciences Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 19, 2025 regarding Roivant Sciences Ltd. (ROIV).